EP2393486A4 - Aceclofenac-haltige orale arzneimittelpräparate mit kontrollierter freisetzung und ihr herstellungsverfahren - Google Patents

Aceclofenac-haltige orale arzneimittelpräparate mit kontrollierter freisetzung und ihr herstellungsverfahren

Info

Publication number
EP2393486A4
EP2393486A4 EP09839738A EP09839738A EP2393486A4 EP 2393486 A4 EP2393486 A4 EP 2393486A4 EP 09839738 A EP09839738 A EP 09839738A EP 09839738 A EP09839738 A EP 09839738A EP 2393486 A4 EP2393486 A4 EP 2393486A4
Authority
EP
European Patent Office
Prior art keywords
aceclofenac
manufacturing process
release oral
oral drug
drug preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09839738A
Other languages
English (en)
French (fr)
Other versions
EP2393486A1 (de
Inventor
Beom-Jin Lee
Youn-Woong Choi
Byung-Gu Min
Seung-Ho An
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea United Pharm Inc
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of EP2393486A1 publication Critical patent/EP2393486A1/de
Publication of EP2393486A4 publication Critical patent/EP2393486A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP09839738A 2009-02-04 2009-04-29 Aceclofenac-haltige orale arzneimittelpräparate mit kontrollierter freisetzung und ihr herstellungsverfahren Withdrawn EP2393486A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090008830A KR101050076B1 (ko) 2009-02-04 2009-02-04 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
PCT/KR2009/002251 WO2010090371A1 (en) 2009-02-04 2009-04-29 Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process

Publications (2)

Publication Number Publication Date
EP2393486A1 EP2393486A1 (de) 2011-12-14
EP2393486A4 true EP2393486A4 (de) 2012-10-10

Family

ID=42542247

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09839738A Withdrawn EP2393486A4 (de) 2009-02-04 2009-04-29 Aceclofenac-haltige orale arzneimittelpräparate mit kontrollierter freisetzung und ihr herstellungsverfahren

Country Status (5)

Country Link
EP (1) EP2393486A4 (de)
KR (1) KR101050076B1 (de)
CN (1) CN102307575B (de)
RU (1) RU2493843C2 (de)
WO (1) WO2010090371A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101234254B1 (ko) * 2010-06-01 2013-02-18 한국유나이티드제약 주식회사 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제
KR20120092993A (ko) * 2011-02-14 2012-08-22 지엘팜텍 주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
KR20130117128A (ko) * 2012-04-17 2013-10-25 한국유나이티드제약 주식회사 레보드로프로피진 함유 서방정 및 이의 제조방법
MX348595B (es) * 2013-08-02 2017-06-21 Laboratorio Raam De Sahuayo S A De C V Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
CN107964454B (zh) * 2017-12-21 2021-03-26 广州合诚三先生物科技有限公司 一种油溶的迷迭香抗氧化剂及其制备方法
KR102126282B1 (ko) * 2018-08-28 2020-07-08 울산과학기술원 중공형 나노구조체를 이용한 상온구동형 가스센서 및 이의 제조방법
KR102236650B1 (ko) * 2019-04-16 2021-04-07 한국유나이티드제약 주식회사 아세클로페낙을 포함하는 약학조성물 및 이의 제조방법
CN117530928A (zh) * 2023-11-10 2024-02-09 中国药科大学 一种醋氯芬酸缓释片的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004060A1 (en) * 2001-07-03 2003-01-16 Pharm Tech Research, Inc. Compositions and preparation methods for bioavailable oral aceaceclofenac dosage forms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
CN1239162C (zh) * 2004-02-05 2006-02-01 晏四平 治疗疼痛的药物组合物
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
US8895061B2 (en) * 2007-03-02 2014-11-25 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
CN100528144C (zh) * 2007-07-13 2009-08-19 浙江尖峰药业有限公司 醋氯芬酸缓释片及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004060A1 (en) * 2001-07-03 2003-01-16 Pharm Tech Research, Inc. Compositions and preparation methods for bioavailable oral aceaceclofenac dosage forms

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MUTALIK SRINIVAS ET AL: "Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.", AAPS PHARMSCITECH 2008 LNKD- PUBMED:18500561, vol. 9, no. 2, 2008, pages 651 - 659, XP009162322, ISSN: 1530-9932 *
S. MUTALIK ET AL: "Preparation,In vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac", ARCHIVES OF PHARMACAL RESEARCH, vol. 30, no. 2, 1 February 2007 (2007-02-01), pages 222 - 234, XP055036579, ISSN: 0253-6269, DOI: 10.1007/BF02977698 *
See also references of WO2010090371A1 *

Also Published As

Publication number Publication date
WO2010090371A1 (en) 2010-08-12
KR101050076B1 (ko) 2011-07-19
EP2393486A1 (de) 2011-12-14
RU2011132480A (ru) 2013-03-10
KR20100089532A (ko) 2010-08-12
CN102307575B (zh) 2013-02-13
CN102307575A (zh) 2012-01-04
RU2493843C2 (ru) 2013-09-27

Similar Documents

Publication Publication Date Title
IL220037A0 (en) Compressible-coated pharmaceutical composiitons and tablets and methods of manufacture
EP2481739A4 (de) Dihydropteridinonderivate, herstellungsverfahren dafür und pharmazeutische anwendung davon
IL245050A0 (en) Optimum fc variants, pharmaceutical preparations and drugs containing them, and a method for their preparation
SI2273975T1 (sl) Farmacevtske raztopine, postopek priprave in terapevtska uporaba
IL208774A0 (en) Compositions comprising weakly basic drugs and controlled-release dosage forms
ZA201003692B (en) Oral care product and methods of use and manufacturing thereof
IL225637A0 (en) The compositions, tablets containing such compositions, their use and a process for their preparation
HUE042105T2 (hu) Oxikodont és naloxont tartalmazó azonnali hatóanyagleadású orális gyógyászati készítmények
EP2393486A4 (de) Aceclofenac-haltige orale arzneimittelpräparate mit kontrollierter freisetzung und ihr herstellungsverfahren
ZA201109510B (en) Nanodispersion of a drug and process for its preparation
IL202179A0 (en) Pharmaceutical solid preparation comprising benzazepines and production method thereof
EP2453886A4 (de) Pharmazeutikum zur oralen verabreichung umfassend mgbg und verfahren zur behandlung einer krankheit
ZA201204441B (en) Granules for pharmaceutical preparations,methods and apparatus for their production
IL213671A (en) Pharmaceutical preparations containing alglitazar, a process for their preparation and use for the preparation of medicines
EP2601955A4 (de) Adsorptionsmittel zur oralen verabreichung, verfahren zu seiner herstellung und arzneimittel damit
ZA201204670B (en) Seven-membered ring compound and pharmaceutical use therefor
EP2454374A4 (de) Orale impfstoffe die unter verwendung von essbarem mikroorganismus hergestellt und verabreicht werden
IL213105A (en) Compounds, their preparation process, pharmaceutical preparations containing them and their use in the preparation of drugs
IL219872A (en) Quinazoline derivatives, their uses, their preparation, and their medications
ZA201109501B (en) Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
GB0922537D0 (en) Pharmaceutical preparation
EP2474294A4 (de) Präparat zur oralen verabreichung
EP2415467A4 (de) Verfahren zur herstellung eines ubichinonpulvers zur verwendung in präparaten und produkt daraus
PT2255677E (pt) Formulação de sucralose e processo de produção desta
GB0906003D0 (en) Oral drug formulation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20110727

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LEE, BEOM-JIN

Inventor name: MIN, BYUNG-GU

Inventor name: AN, SEUNG-HO

Inventor name: CHOI, YOUN-WOONG

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20120912

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20120906BHEP

Ipc: A61K 9/24 20060101AFI20120906BHEP

Ipc: A61K 9/54 20060101ALI20120906BHEP

Ipc: A61K 47/30 20060101ALI20120906BHEP

Ipc: A61K 9/22 20060101ALI20120906BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/24 20060101AFI20130110BHEP

Ipc: A61K 9/22 20060101ALI20130110BHEP

Ipc: A61K 9/20 20060101ALI20130110BHEP

Ipc: A61K 47/30 20060101ALI20130110BHEP

Ipc: A61K 9/54 20060101ALI20130110BHEP

17Q First examination report despatched

Effective date: 20130121

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20151106

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LEE, BEOM-JIN

Inventor name: CHOI, YOUN-WOONG

Inventor name: MIN, BYUNG-GU

Inventor name: AN, SEUNG-HO

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160317